Log in to save to my catalogue

Genome-scale CRISPR screening for modifiers of cellular LDL uptake

Genome-scale CRISPR screening for modifiers of cellular LDL uptake

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b69d1bece3cb4a27a991ea55effe4e85

Genome-scale CRISPR screening for modifiers of cellular LDL uptake

About this item

Full title

Genome-scale CRISPR screening for modifiers of cellular LDL uptake

Publisher

United States: Public Library of Science

Journal title

PLoS genetics, 2021-01, Vol.17 (1), p.e1009285-e1009285

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Hypercholesterolemia is a causal and modifiable risk factor for atherosclerotic cardiovascular disease. A critical pathway regulating cholesterol homeostasis involves the receptor-mediated endocytosis of low-density lipoproteins into hepatocytes, mediated by the LDL receptor. We applied genome-scale CRISPR screening to query the genetic determinant...

Alternative Titles

Full title

Genome-scale CRISPR screening for modifiers of cellular LDL uptake

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b69d1bece3cb4a27a991ea55effe4e85

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b69d1bece3cb4a27a991ea55effe4e85

Other Identifiers

ISSN

1553-7404,1553-7390

E-ISSN

1553-7404

DOI

10.1371/journal.pgen.1009285

How to access this item